NAGIOS: RODERIC FUNCIONANDO

Cost of type 2 diabetes patients with chronic kidney disease based on real-world data : an observational population-based study in Spain

DSpace Repository

Cost of type 2 diabetes patients with chronic kidney disease based on real-world data : an observational population-based study in Spain

dc.contributor.author	Usó Talamentes, Ruth
dc.contributor.author	González de Julián, Silvia
dc.contributor.author	Díaz Carnicero, Javier
dc.contributor.author	Saurí Ferrer, Inmaculada
dc.contributor.author	Trillo-Mata, Jose Luis
dc.contributor.author	Carrasco Pérez, Marc
dc.contributor.author	Navarro Pérez, Jorge
dc.contributor.author	Górriz Teruel, Jose Luis
dc.contributor.author	Vivas Consuelo, David
dc.contributor.author	Redón i Más, Josep
dc.date.accessioned	2022-06-15T17:24:32Z
dc.date.available	2022-06-15T17:24:32Z
dc.date.issued	2021
dc.identifier.uri	https://hdl.handle.net/10550/83165
dc.description.abstract	This study analyzed the prevalence, costs and economic impact of chronic kidney disease CKD in patients with T2D in a Spanish Health District using real-world data. Observational cross-sectional study in adult patients with T2D was through data extracted from the information systems of the Valencia Clínico-La Malvarrosa Health District in the year 2015. Patients were stratified with the KDIGO classification for CKD. Additionally, patients were assigned to Clinical Risk Groups (CRGs) according to multimorbidity. Direct costs of primary and specialized care, and medication were estimated. The prevalence of T2D in the database population (n = 28,345) was 10.8% (mean age (SD) = 67.8 years (13.9); 51.5% male). Up to 14.935 patients (52.6%) had data on kidney function. According to the KDIGO classification, 66.2% of the patients were at low risk of CKD, 20.6% at moderately increased risk, 7.9% at high risk, and 5.2% at very high risk. The average healthcare costs associated with these four risk groups were EUR 3437, EUR 4936, EUR 5899 and EUR 7389, respectively. The large number of T2D patients with CKD in the early stages of the disease generated a significant increase in direct healthcare costs. The economic impact could be mitigated by early and comprehensive therapeutic approaches
dc.language.iso	eng
dc.relation.ispartof	International Journal Of Environmental Research And Public Health, 2021
dc.source	Usó Talamentes, Ruth González de Julián, Silvia Díaz Carnicero, Javier Saurí Ferrer, Inmaculada Trillo Mata, José Luís Carrasco Pérez, Marc Navarro Pérez, Jorge Górriz Teruel, Jose Luis Vivas Consuelo, David Redón i Más, Josep 2021 Cost of type 2 diabetes patients with chronic kidney disease based on real-world data : an observational population-based study in Spain International Journal Of Environmental Research And Public Health
dc.subject	Diabetis
dc.subject	Insuficiència renal crònica
dc.title	Cost of type 2 diabetes patients with chronic kidney disease based on real-world data : an observational population-based study in Spain
dc.type	journal article	es_ES
dc.date.updated	2022-06-15T17:24:32Z
dc.identifier.doi	https://doi.org/10.3390/ijerph18189853
dc.identifier.idgrec	154216
dc.rights.accessRights	open access	es_ES